Open Access Open Access  Restricted Access Subscription Access

Understanding Drugs Acting on Vaginal Granuloma: A Comprehensive Overview

Ramanjaneyulu ., Sravani Pragna K., Muralinath E., Kalyan C. Chakravarthi, Sony Sharlet E., Sai Hemachand N., Manjari P., Sravani K., Guru Prasad M.

Abstract


Vaginal granulomas are abnormal growth or nodules that can develop on the vaginal canal. They frequently occur from various factors namely infections, trauma or foreign body reactions. Treatment include topical steroids, Antibiotics, Antifungal, Immuno modulators, Analgesics and hormonal Treatment Finally it is concluded that the treatment of vaginal granuloma needs a tailored approach. Based on the underlying causes and individual patient characteristics.


Full Text:

PDF

References


Mabey, D., & Peeling, R. W. (2002). Lymphogranuloma venereum. Sexually transmitted infections, 78(2), 90-92.

Workowski, K. A. (2015). Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases, 61(suppl_8), S759-S762.

Blank, S., Schillinger, J. A., & Harbatkin, D. (2005). Lymphogranuloma venereum in the industrialised world. The Lancet, 365(9471), 1607-1608.

Nieuwenhuis, R. F., Ossewaarde, J. M., Götz, H. M., Dees, J., Thio, H. B., Thomeer, M. G., ... & van der Meijden, W. I. (2004). Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men. Clinical infectious diseases, 39(7), 996-1003.

Spaargaren, J., Fennema, H. S., Morré, S. A., De Vries, H. J., & Coutinho, R. A. (2005). New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerging infectious diseases, 11(7), 1090.

Chen, J. C. R., & Stephens, R. S. (1994). Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan‐dependent mechanism for infection of eukaryotic cells. Molecular microbiology, 11(3), 501-507.

Ceovic, R., & Gulin, S. J. (2015). Lymphogranuloma venereum: diagnostic and treatment challenges. Infection and drug resistance, 39-47.

Rönn, M. M., & Ward, H. (2011). The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis. BMC infectious diseases, 11, 1-8.

Su, H. U. A., Raymond, L., Rockey, D. D., Fischer, E., Hackstadt, T. E. D., & Caldwell, H. D. (1996). A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proceedings of the National Academy of Sciences, 93(20), 11143-11148.

Dal Conte, I., Mistrangelo, M., Cariti, C., Chiriotto, M., Lucchini, A., Vigna, M., ... & Di Perri, G. (2014). An old, forgotten re-emerging systemic disease. Panminerva Med, 56, 73-83.

Harrison, T., Som, M., & Stroup, J. (2016, October). Lymphogranuloma venereum proctitis. In Baylor University Medical Center Proceedings (Vol. 29, No. 4, pp. 418-419). Taylor & Francis.

Schachter, J., & Alexander, E. R. (2009). Chlamydial infections. Bacterial infections of humans: epidemiology and control, 221-247.

Papp, J. R., Schachter, J., Gaydos, C. A., & Van Der Pol, B. (2014). Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014. MMWr recomm rep, 63(RR-02), 1-19.

Bachmann, L. H., Johnson, R. E., Cheng, H., Markowitz, L., Papp, J. R., Palella Jr, F. J., & Hook III, E. W. (2010). Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. Journal of clinical microbiology, 48(5), 1827-1832.

Meyer, T. (2016). Diagnostic procedures to detect Chlamydia trachomatis infections. Microorganisms, 4(3), 25.

Handsfield, H. H. (2018). Lymphogranuloma venereum treatment and terminology. Sexually Transmitted Diseases, 45(6), 409-411.


Refbacks

  • There are currently no refbacks.